vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
R F INDUSTRIES LTD is the larger business by last-quarter revenue ($22.7M vs $13.8M, roughly 1.6× FENNEC PHARMACEUTICALS INC.). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -34.7%, a 35.5% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 22.9%). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
FENC vs RFIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $22.7M |
| Net Profit | $-4.8M | $173.0K |
| Gross Margin | — | 36.8% |
| Operating Margin | -18.5% | 4.0% |
| Net Margin | -34.7% | 0.8% |
| Revenue YoY | 73.8% | 22.9% |
| Net Profit YoY | -141.1% | 172.7% |
| EPS (diluted) | $-0.17 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $22.7M | ||
| Q3 25 | $12.5M | $19.8M | ||
| Q2 25 | $9.7M | $18.9M | ||
| Q1 25 | $8.8M | $19.2M | ||
| Q4 24 | $7.9M | $18.5M | ||
| Q3 24 | $7.0M | $16.8M | ||
| Q2 24 | $7.3M | $16.1M | ||
| Q1 24 | $25.4M | $13.5M |
| Q4 25 | $-4.8M | $173.0K | ||
| Q3 25 | $-638.0K | $392.0K | ||
| Q2 25 | $-3.2M | $-245.0K | ||
| Q1 25 | $-1.2M | $-245.0K | ||
| Q4 24 | $-2.0M | $-238.0K | ||
| Q3 24 | $-5.7M | $-705.0K | ||
| Q2 24 | $-5.6M | $-4.3M | ||
| Q1 24 | $12.8M | $-1.4M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 24.5% |
| Q4 25 | -18.5% | 4.0% | ||
| Q3 25 | -1.5% | 3.6% | ||
| Q2 25 | -28.3% | 0.6% | ||
| Q1 25 | -9.2% | 0.3% | ||
| Q4 24 | -11.8% | 0.5% | ||
| Q3 24 | -74.6% | -2.5% | ||
| Q2 24 | -69.4% | -2.6% | ||
| Q1 24 | 54.2% | -15.5% |
| Q4 25 | -34.7% | 0.8% | ||
| Q3 25 | -5.1% | 2.0% | ||
| Q2 25 | -32.7% | -1.3% | ||
| Q1 25 | -13.3% | -1.3% | ||
| Q4 24 | -25.0% | -1.3% | ||
| Q3 24 | -82.2% | -4.2% | ||
| Q2 24 | -76.5% | -26.7% | ||
| Q1 24 | 50.6% | -10.1% |
| Q4 25 | $-0.17 | $0.01 | ||
| Q3 25 | $-0.02 | $0.04 | ||
| Q2 25 | $-0.11 | $-0.02 | ||
| Q1 25 | $-0.04 | $-0.02 | ||
| Q4 24 | $-0.02 | $-0.02 | ||
| Q3 24 | $-0.21 | $-0.07 | ||
| Q2 24 | $-0.20 | $-0.41 | ||
| Q1 24 | $0.41 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $35.2M |
| Total Assets | $70.6M | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $5.1M | ||
| Q3 25 | $21.9M | $3.0M | ||
| Q2 25 | $18.7M | $3.6M | ||
| Q1 25 | $22.7M | $1.3M | ||
| Q4 24 | $26.6M | $839.0K | ||
| Q3 24 | $40.3M | $1.8M | ||
| Q2 24 | $43.1M | $1.4M | ||
| Q1 24 | $51.2M | $4.5M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $35.2M | ||
| Q3 25 | $-4.5M | $34.8M | ||
| Q2 25 | $-7.5M | $34.2M | ||
| Q1 25 | $-5.9M | $34.2M | ||
| Q4 24 | $-5.9M | $34.1M | ||
| Q3 24 | $-5.2M | $34.1M | ||
| Q2 24 | $-1.4M | $34.6M | ||
| Q1 24 | $3.0M | $38.7M |
| Q4 25 | $70.6M | $73.0M | ||
| Q3 25 | $49.3M | $73.2M | ||
| Q2 25 | $44.9M | $72.7M | ||
| Q1 25 | $46.4M | $70.4M | ||
| Q4 24 | $44.9M | $71.0M | ||
| Q3 24 | $58.9M | $71.9M | ||
| Q2 24 | $63.2M | $72.8M | ||
| Q1 24 | $69.2M | $79.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $2.1M |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 9.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $2.1M | ||
| Q3 25 | $1.5M | $-311.0K | ||
| Q2 25 | $-3.7M | $2.2M | ||
| Q1 25 | $-4.3M | $601.0K | ||
| Q4 24 | $-1.5M | $-244.0K | ||
| Q3 24 | $-2.2M | $2.4M | ||
| Q2 24 | $-8.4M | $197.0K | ||
| Q1 24 | $39.0M | $840.0K |
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-419.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $574.0K | ||
| Q4 24 | — | $-418.0K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $28.0K | ||
| Q1 24 | — | $697.0K |
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
